Weekly carboplatin in combination with weekly paclitaxel in the treatment of metastatic non-small cell lung cancer: a single center 10-year experience

被引:0
作者
Viktoria Volk
Richard Cathomas
Michael Mark
Roger von Moos
Dirk Klingbiel
Peter Brossart
Ulrich Mey
机构
[1] University of Bonn,Department of Internal Medicine III
[2] Kantonsspital Graubünden,Department of Medical Oncology and Hematology
[3] Statistics Unit,undefined
[4] SAKK Swiss Group for Cancer Research Coordinating Center,undefined
来源
Supportive Care in Cancer | 2016年 / 24卷
关键词
Non-small cell lung cancer; Weekly; Carboplatin; Paclitaxel;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2119 / 2128
页数:9
相关论文
共 75 条
[1]  
Reck M(2014)Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 25 iii27-iii39
[2]  
Popat S(2002)Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer N Engl J Med 346 92-98
[3]  
Reinmuth N(2001)Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a Southwest Oncology Group trial J Clin Oncol 19 3210-3218
[4]  
Schiller JH(2005)Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730) J Clin Oncol 23 190-196
[5]  
Schiller JH(2006)Paclitaxel–carboplatin alone or with bevacizumab for non-small-cell lung cancer N Engl J Med 355 2542-2550
[6]  
Harrington D(2008)Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer J Clin Oncol 26 468-473
[7]  
Kelly K(2006)Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials Intern Med J 36 216-220
[8]  
Crowley J(1999)Underrepresentation of patients 65 years of age or older in cancer-treatment trials N Engl J Med 341 2061-2067
[9]  
Bunn PA(2005)Non-small-cell lung cancer in a French department, (1982–1997): management and outcome Br J Cancer 92 459-466
[10]  
Lilenbaum RC(2011)Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial Lancet 378 1079-1088